BSEInsider Trading / SAST12 Oct 2026 · 12 Oct 2026, 05:41 pm
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Counter Cyclical Investment Pvt Ltd
Jenburkt Pharmaceuticals Ltd · 524731
✦ AI SummaryRelated Party
Jenburkt Pharmaceuticals Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Counter Cyclical Investment Pvt Ltd.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jenburkt Pharmaceuticals Ltd - 524731 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011